The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Sonoma Pharmaceuticals's share price is $0.156.
Sonoma Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.22. Hence, Sonoma Pharmaceuticals's PS Ratio for today is 0.07.
The historical rank and industry rank for Sonoma Pharmaceuticals's PS Ratio or its related term are showing as below:
SNOA'
s PS Ratio Range Over the Past 10 Years
Min: 0.05 Med: 0.77 Max: 2.82
Current: 0.07
During the past 13 years, Sonoma Pharmaceuticals's highest PS Ratio was 2.82. The lowest was 0.05. And the median was 0.77.
SNOA's PS Ratio is ranked better than 98.9% of 1001
companies
in the Drug Manufacturers industry
Industry Median: 2.21
vs SNOA: 0.07
Sonoma Pharmaceuticals Inc revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Sonoma Pharmaceuticals was -45.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -31.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -35.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -28.70% per year.
During the past 13 years, Sonoma Pharmaceuticals's highest 3-Year average Revenue per Share Growth Rate was 52.60% per year. The lowest was -43.10% per year. And the median was -19.00% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sonoma Pharmaceuticals's PS Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, Sonoma Pharmaceuticals's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sonoma Pharmaceuticals's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sonoma Pharmaceuticals's PS Ratio distribution charts can be found below:
* The bar in red indicates where Sonoma Pharmaceuticals's PS Ratio falls into.
Sonoma Pharmaceuticals PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Sonoma Pharmaceuticals's Share Price of today is $0.156. Sonoma Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.22.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Sonoma Pharmaceuticals (NAS:SNOA) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Sonoma Pharmaceuticals PS Ratio Related Terms
Thank you for viewing the detailed overview of Sonoma Pharmaceuticals's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Sonoma Pharmaceuticals (Sonoma Pharmaceuticals) Business Description
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SNOA has been successfully added to your 